Alphatec Holdings designs and commercializes spinal surgery systems under the Alphatec Spine brand, spanning implants, instruments, and enabling technologies for fusion and related procedures. The company focuses on procedural solutions that integrate hardware with navigation, imaging, and information tools aimed at improving surgical reproducibility. Its customers are primarily spine surgeons and hospitals seeking specialized implants and workflow-oriented operating-room platforms.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 185.5 | — | -41.1 | — |
| Q3 2025 | 196.5 | — | -28.6 | — |
| Q4 2025 | 212.9 | — | -21.7 | — |
| Q1 2026 | 192.1 | — | -33.9 | — |
| Q2 2026 | 213.5 | 15.1% | -25.8 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Replimune Group, Inc. (REPL), Aktis Oncology, Inc. (AKTS), Burke & Herbert Financial Services Corp. (BHRB), Amalgamated Financial Corp. (AMAL), WEBTOON Entertainment Inc. (WBTN), Azenta, Inc. (AZTA)